B-M cash gaffe: drugs client faces sanction
A top drugs company is to be named and shamed for 'bringing discredit upon, and reducing confidence in' the pharma industry following a Burson-Marsteller blunder.
Sign in to continue
Need to activate your subscription?
Domain/Group Subscriptions
Click here >>
Individual Subscriptions
Click here >>
Need to activate your Subscription
Company Wide Subscriptions
Click here >>
UK Individual Subscribers
Click here >>